bioRxivBiochemistryPreprint
CLN8 enables a non-canonical phospholipid synthesis pathway
Johannes BreithoferiD, Nermeen FawzyiD, Clara ZittaiD, Martin TischitziD, Dominik BulfoniD, Clemens HofmanniD, Lennart HartigiD, Carina WagneriD, Gernot F. GrabneriD, Anita Pirchheim, Achim LassiD, Ulrike TaschleriD, Keira TurneriD, Kasparas PetkeviciusiD, Ulrich StelzliD, Dagmar KratkyiD, Rolf BreinbaueriD, Robert ZimmermanniD
Abstract
According to text book knowledge, de novo glycerophospholipid (GPL) synthesis begins with the acylation of glycerol-3-phosphate to form phosphatidic acid, the precursor of all other GPLs. Here we describe an alternative GPL synthesis pathway that starts with the acyl-CoA-dependent acylation of glycerophosphoglycerol (GPG), resulting in the formation of lysophosphatidylglycerol (LPG). The acyltransferase reaction is catalyzed by the Batten disease-associated protein ceroid lipofuscinosis neuronal 8 (CLN8). Tracer studies revealed that CLN8-derived LPG is selectively converted into bis(monoacylglycero)phosphate (BMP), a GPL essential for lysosomal lipid homeostasis, but not into phosphatidylglycerol or cardiolipin. CLN8-knockout cells and mice cannot utilize GPG for BMP synthesis, resulting in BMP-deficiency and excess accumulation of phospholipids in lysosomes. The lipid synthesis pathway described herein is relevant for understanding lysosomal lipid metabolism and the pathogenesis of neurodegenerative diseases. BMP-deficiency may contribute to or even underlie lysosomal cargo accumulation in certain forms of Batten disease and other lysosomal storage disorders.
- organism: human
- organism: mouse
- assay: metabolomics
- research focus: metabolism & bioenergetics
- research focus: differential expression
- approach: experimental assay
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Stereospecific GPG acylation by CLN8 drives BMP biosynthesis and its loss leads to Batten disease
Pradeep Kumar Sheokand, Denis Lacabanne, … Kasparas Petkevicius·Nature Cell BiologyPeer-reviewed·Sep 15, 2026
- CLN6 is a glycerophosphoglycerol epimerase in bis(monoacylglycero)phosphate biosynthesis
Pradeep Kumar Sheokand, Andrew M. James, … Kasparas Petkevicius·bioRxiv·Oct 9, 2026
- The endolysosomal phospholipid bis(monoacylglycero)phosphate is synthesized via intra- and extracellular pathways
Dominik Bulfon, Johannes Breithofer, … Robert Zimmermann·Nature CommunicationsPeer-reviewed·Nov 15, 2024
- The Batten disease gene product CLN6 is a glycerophosphoglycerol epimerase that establishes S,S-BMP stereochemistry
Zhijun Zhu, Jian Xiong, … Monther Abu-Remaileh·bioRxiv·Oct 9, 2026
- Translational lipidomics reveals BMP and its precursor LPG as biomarkers for CLN5 Batten disease
Eshaan S. Rawat, Nick Manfred, … Monther Abu-Remaileh·bioRxiv·Mar 21, 2026
- A Novel Process Maintaining Glycerophospholipid Homeostasis in Mammalian Cells
M. Hermansson, S. M. Hanninen, … P. Somerharju·bioRxiv·Nov 13, 2019